Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B cells in multiple sclerosis.

Mark P Burgoon1, Donald H Gilden, Gregory P Owens

  • 1Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA. mark.burgoon@uchsc.edu

Frontiers in Bioscience : a Journal and Virtual Library
|February 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extensive peripheral immunoglobulin repertoire analyses in people with multiple sclerosis reveal disease-specific signatures and distinct treatment effects of disease modifying drugs.

Journal of neuroinflammation·2026
Same author

Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica.

Acta neuropathologica communications·2025
Same author

Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1-anchored membrane domains.

The Journal of clinical investigation·2023
Same author

Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses.

Frontiers in immunology·2021
Same author

Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.

Experimental neurology·2019
Same author

Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.

The Journal of clinical investigation·2019
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

The most common lab abnormality in multiple sclerosis (MS) involves cerebrospinal fluid IgG and oligoclonal bands. Identifying the targets of this immune response is crucial for understanding MS causes and developing treatments.

Area of Science:

  • Neurology
  • Immunology
  • Neuroimmunology

Background:

  • Multiple sclerosis (MS) commonly shows increased cerebrospinal fluid IgG and oligoclonal bands.
  • The specific targets of the oligoclonal immune response in MS remain unidentified.
  • Understanding these targets is key to elucidating MS pathogenesis.

Purpose of the Study:

  • To identify the major targets of the oligoclonal response in multiple sclerosis.
  • To gain insights into the infectious agents or autoantigens involved in MS.

Main Methods:

  • Analysis of cerebrospinal fluid IgG and oligoclonal bands.
  • Investigating humoral immune responses in MS patients.

Main Results:

  • The primary targets of the oligoclonal response in MS are currently unknown.

Related Experiment Videos

  • Studies suggest potential involvement of infectious agents or autoantigens.

    • Conclusions:

    • Identifying oligoclonal band targets is essential for understanding MS etiology.
    • Discovery of targets may lead to novel therapeutic strategies for multiple sclerosis.